Ginès P , Krag A , Abraldes J G , et al . Liver cirrhosis [J ] . Lancet (London, England) , 2021 , 398 ( 10308 ): 1359 - 1376 .

Zhang J , Lin S , Jiang D , et al . Chronic hepatitis B and non-alcoholic fatty liver disease: Conspirators or competitors? [J ] . Liver International: Official Journal of the International Association for the Study of the Liver , 2020 , 40 ( 3 ): 496 - 508 .

Huang S C , Liu C J . Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives [J ] . Clinical and Molecular Hepatology , 2023 , 29 ( 2 ): 320 - 331 .

Gaber Y , AbdAllah M , Salama A , et al . Metabolic-associated fatty liver disease and autoimmune hepatitis: an overlooked interaction [J ] . Expert Review of Gastroenterology & Hepatology , 2021 , 15 ( 10 ): 1181 - 1189 .

Hernández-Pérez M , Riado D , Pena E , et al . The overlap with metabolic dysfunction-associated steatotic liver disease negatively affects outcomes of primary biliary cholangitis [J ] . Alimentary pharmacology & therapeutics , 2024 , 60 ( 5 ): 613 - 619 .

Zhang Y , Meng F , Hu X , et al . Comparative diagnostic efficacy of two-dimensional shear wave and transient elastography in predicting the risk of esophagogastric varices and histological staging in patients with primary biliary cholangitis [J ] . BMC gastroenterology , 2024 , 24 ( 1 ): 396 .

Steinmann S , Hartl J , Weidemann S , et al . Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases [J ] . JHEP reports: innovation in hepatology , 2023 , 5 ( 12 ): 100898 .

Ni X X , Lian M , Wu H M , et al . Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases [J ] . World Journal of Gastroenterology , 2021 , 27 ( 1 ): 80 - 91 .